Patient groups have done a great job raising awareness of prostate cancer – although still can’t quite bring ourselves to moustaches in Movember. Fortunately detection and diagnosis are also improving and as this review in the Telegraph reports, RhoVac could deliver a real breakthrough this year with their immunotherapy targeting the RhoC protein. It seems to be a key driver of metastasis and if blocked could effectively block remission. https://www.rhovac.com